Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × nintedanib × Clear all

NCT02182063 2017-12-28

A Study With BIBF 1120 in Patients With Hormone Refractory Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00706628 2015-01-15

A Multi-centre 3-arm Randomised Phase II Trial of BIBF 1120 Versus BIBW 2992 Versus Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Hormone-resistant Prostate Cancer

Phase 2 Completed

87 enrolled 20 charts

Prostatic Neoplasms